20
Participants
Start Date
September 21, 2015
Primary Completion Date
May 31, 2019
Study Completion Date
May 31, 2019
HIFU (Focal One®)
Endometriosic lesion localization and HIFU treatment will be conducted with the Focal One® device. The treatment area will be defined using sonography, pelvic MRI and a transrectal sonography data. Once the pre-defined lesion will be located with Focal One device, succession of HIFU exposure will then be used to treat maximum lesion volume, excluding a security margin of 3 mm with the digestive mucosae.
Hôpital de la Croix Rousse, Lyon
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
EDAP TMS S.A.
INDUSTRY